- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Dermatomycoses
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Dermatomycoses
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Dermatomycoses pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/dermatomycoses-pipelinereview-h1-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Dermatomycoses Overview 6
Therapeutics Development 7
Pipeline Products for Dermatomycoses - Overview 7
Pipeline Products for Dermatomycoses - Comparative Analysis 8
Dermatomycoses - Therapeutics under Development by Companies 9
Dermatomycoses - Therapeutics under Investigation by Universities/Institutes 10
Dermatomycoses - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Unknown Stage Products 14
Dermatomycoses - Products under Development by Companies 15
Dermatomycoses - Products under Investigation by Universities/Institutes 16
Dermatomycoses - Companies Involved in Therapeutics Development 17
Anacor Pharmaceuticals, Inc. 17
Blueberry Therapeutics Ltd 18
Daewoong Pharmaceutical Co., Ltd. 19
Helix BioMedix, Inc. 20
TGV-Laboratories 21
Viamet Pharmaceuticals, Inc. 22
Dermatomycoses - Therapeutics Assessment 23
Assessment by Monotherapy Products 23
Assessment by Target 24
Assessment by Mechanism of Action 26
Assessment by Route of Administration 28
Assessment by Molecule Type 30